$74.68
+0.88 (+1.19%)
Open$71.35
Previous Close$73.80
Day High$74.70
Day Low$71.34
52W High$97.97
52W Low$6.96
Volume—
Avg Volume36.5K
Market Cap243.41M
P/E Ratio—
EPS$-0.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
-83.4% upside
Current
$74.68
$74.68
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 24.19M | 14.15M | 80.43M |
| Net Income | -7,645,380 | -4,024,825 | 27.17M |
| Profit Margin | -31.6% | -30.0% | 33.8% |
| EBITDA | -9,270,193 | -5,151,312 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | +71.0% | +71.0% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |